Inventor
WOODLE MARTIN C
US18 patents
⚠️ This page may combine multiple inventors who share the name “WOODLE MARTIN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRADIGM CORP
6 patentsUS7723316B2May 25, 2010
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP12 citations91
US7534878B2May 19, 2009
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP22 citations91
US7893244B2Feb 22, 2011
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP7 citations82
US7786092B2Aug 31, 2010
Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP11 citations82
US7893243B2Feb 22, 2011
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP6 citations72
US7781414B2Aug 24, 2010
Targets for tumor growth inhibition
INTRADIGM CORP2 citations58
LIPOSOME TECHNOLOGY INC
5 patentsUS5395619AMar 7, 1995
Lipid-polymer conjugates and liposomes
LIPOSOME TECHNOLOGY INC566 citations98
US5225212AJul 6, 1993
Microreservoir liposome composition and method
LIPOSOME TECHNOLOGY INC754 citations98
US5213804AMay 25, 1993
Solid tumor treatment method and composition
LIPOSOME TECHNOLOGY INC682 citations98
US5013556AMay 7, 1991
Liposomes with enhanced circulation time
LIPOSOME TECHNOLOGY INC2,874 citations98
US5356633AOct 18, 1994
Method of treatment of inflamed tissues
LIPOSOME TECHNOLOGY INC532 citations96
SEQUUS PHARM INC
4 patentsUS6180134B1Jan 30, 2001
Enhanced ciruclation effector composition and method
SEQUUS PHARM INC130 citations99
US5631018AMay 20, 1997
Lipid-polymer conjugates and liposomes
SEQUUS PHARM INC349 citations98
US5843473ADec 1, 1998
Method of treatment of infected tissues
SEQUUS PHARM INC111 citations94
US6326353B1Dec 4, 2001
Enhanced circulation effector composition and method
SEQUUS PHARM INC19 citations92